
Low productivity in the pharmaceutical industry positions personalized medicine and companion zzso as an attractive zzso The zzso community is enthusiastic and optimistic that advances in molecular zzso have the potential to materialize the dream of personalized cancer therapy with the aim to: help the drug industry enhance the probability of success and, probably, accelerate time to market; help the zzso industry develop diagnostic tests utilizing precious human zzso and support accurate diagnosis and selection of the most zzso and least toxic zzso However, this spectacular road is not yet paved and remains facing the following biggest challenges: the need for better understanding of biology and limitations of zzso zzso zzso variables that are likely to alter results; zzso zzso and the wide gap between zzso and diagnostic zzso This article explores these challenges, their possible impacts, and provides some suggestions for zzso 

